Bio-Techne's RNAscope Technology Aids In Retrospective Tissue Diagnosis Of COVID-19

(RTTNews) - Bio-Techne Corp. (TECH) said that its RNAscope technology aids in the retrospective tissue diagnosis of covid-19 in cases with no previous testing for SARS-CoV-2.

The company said it is honored that RNAscope aided CDC researchers in the detection of SARS-CoV-2 in the fatal suspected COVID-19 cases without previous testing for SARS-CoV-2 and in advancing the understanding of SARS-CoV-2 pathogenesis.

RNAscope probes have been an essential tool in elucidating the pathology of this devastating virus in over one hundred COVID-19 publications to date.

Based on the results of this and other studies using the RNAscope technology for the detection of SAR-CoV-2, Bio-Techne said its Advanced Cell Diagnostics is launching one of the probes used in the study specific for the Spike protein mRNA as an Analyte Specific Reagent or ASR. The SARS-CoV-2 ASR will provide researchers and pathologists with a powerful technology for the detection of SARS-CoV-2 in fixed tissues.